vs
Side-by-side financial comparison of DYNEX CAPITAL INC (DX) and TRINITY BIOTECH PLC (TRIB). Click either name above to swap in a different company.
DYNEX CAPITAL INC is the larger business by last-quarter revenue ($43.5M vs $30.5M, roughly 1.4× TRINITY BIOTECH PLC).
Dynex Capital Inc. is a publicly traded real estate investment trust headquartered in the United States. It specializes in investing in and managing a diversified portfolio of mortgage-backed securities, residential and commercial mortgage loans, and other mortgage-related assets. It delivers consistent returns to shareholders via regular dividends and long-term capital growth.
Trinity Biotech PLC develops, manufactures and markets diagnostic test kits and systems for clinical laboratories and point-of-care settings. Its product portfolio covers diabetes management, infectious diseases, cardiac health, autoimmune disorders and coagulation, with core markets across North America, Europe and emerging economies.
DX vs TRIB — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2024
| Metric | | |
|---|---|---|
| Revenue | $43.5M | $30.5M |
| Net Profit | — | $-10.1M |
| Gross Margin | — | 36.8% |
| Operating Margin | — | -23.2% |
| Net Margin | — | -33.0% |
| Revenue YoY | 531.3% | — |
| Net Profit YoY | — | — |
| EPS (diluted) | $1.59 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $43.5M | — | ||
| Q3 25 | $30.6M | — | ||
| Q2 25 | $23.1M | — | ||
| Q1 25 | $17.1M | — | ||
| Q2 24 | — | $30.5M | ||
| Q1 24 | $-3.2M | — | ||
| Q4 22 | $6.2M | — | ||
| Q3 22 | $7.1M | — |
| Q4 25 | — | — | ||
| Q3 25 | $150.4M | — | ||
| Q2 25 | $-13.6M | — | ||
| Q1 25 | $-3.1M | — | ||
| Q2 24 | — | $-10.1M | ||
| Q1 24 | $40.1M | — | ||
| Q4 22 | $43.3M | — | ||
| Q3 22 | $-46.7M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 36.8% | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | -23.2% | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 491.3% | — | ||
| Q2 25 | -58.8% | — | ||
| Q1 25 | -18.0% | — | ||
| Q2 24 | — | -33.0% | ||
| Q1 24 | -1256.8% | — | ||
| Q4 22 | 697.2% | — | ||
| Q3 22 | -655.3% | — |
| Q4 25 | $1.59 | — | ||
| Q3 25 | $1.08 | — | ||
| Q2 25 | $-0.14 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.64 | — | ||
| Q4 22 | $0.44 | — | ||
| Q3 22 | $-1.07 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $531.0M | $5.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $2.5B | $-29.4M |
| Total Assets | $17.3B | $94.4M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $531.0M | — | ||
| Q3 25 | $491.0M | — | ||
| Q2 25 | $387.5M | — | ||
| Q1 25 | $327.4M | — | ||
| Q2 24 | — | $5.3M | ||
| Q1 24 | $295.7M | — | ||
| Q4 22 | $332.0M | — | ||
| Q3 22 | $260.4M | — |
| Q4 25 | $2.5B | — | ||
| Q3 25 | $2.0B | — | ||
| Q2 25 | $1.6B | — | ||
| Q1 25 | $1.4B | — | ||
| Q2 24 | — | $-29.4M | ||
| Q1 24 | $958.5M | — | ||
| Q4 22 | $901.3M | — | ||
| Q3 22 | $771.3M | — |
| Q4 25 | $17.3B | — | ||
| Q3 25 | $14.2B | — | ||
| Q2 25 | $11.3B | — | ||
| Q1 25 | $9.0B | — | ||
| Q2 24 | — | $94.4M | ||
| Q1 24 | $6.3B | — | ||
| Q4 22 | $3.6B | — | ||
| Q3 22 | $4.0B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $120.8M | $-3.9M |
| Free Cash FlowOCF − Capex | — | $-4.1M |
| FCF MarginFCF / Revenue | — | -13.3% |
| Capex IntensityCapex / Revenue | — | 0.5% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $120.8M | — | ||
| Q3 25 | $68.3M | — | ||
| Q2 25 | $31.9M | — | ||
| Q1 25 | $6.4M | — | ||
| Q2 24 | — | $-3.9M | ||
| Q1 24 | $-17.1M | — | ||
| Q4 22 | $30.1M | — | ||
| Q3 22 | $25.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | $-4.1M | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | -13.3% | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | 0.5% | ||
| Q1 24 | — | — | ||
| Q4 22 | — | — | ||
| Q3 22 | — | — |
| Q4 25 | — | — | ||
| Q3 25 | 0.45× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -0.43× | — | ||
| Q4 22 | 0.69× | — | ||
| Q3 22 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
